Stasis Labs launches app-connected remote patient monitoring platform in US

On August 26, 2020, Stasis Labs announced that its mobile-connected remote patient monitoring platform for hospital and outpatient use has launched in the U.S.

Stasis Lab, a graduate from the Cedars Sinai Accelerator-TechStars Program, offers portable continuous health monitoring allowing doctors, members of the care team and family to identify clinical changes and intervene before a critical event.

The Stasis system is made up of a smart device, traditional vital sign sensors, a bedside monitor and supporting cloud platform. Through mobile, tablet or desktop apps, care teams can monitor their patients' conditions, review trends and receive notifications when the system detects an issue. Stasis includes sensors measuring heart rate, blood oxygen, respiratory rate, blood pressure, temperature and three-lead ECG. It received a 510(k) clearance in April 2019.

In the lead up to the launch, Stasis Labs has rolled out its platform in “approximately 50 cities,” the majority of which are based in India. They also deployed the system in a limited capacity to U.S. providers such as Texas-based emergency-care provider Hospitality Health ER and California-based Glendale Surgical Center and Orthopedic Surgery Specialists.

“In the outpatient environment, clinicians are always on the move between facilities, and this level of connectivity to their patients and data tracking ensures clinical insights while on-the-move,” CEO Michael Maylahn said in a statement.

In testimonials provided by Stasis Labs, clinicians from Hospitality Health ER and Glendale Surgical Center stressed the ease with which their teams set up the devices for first-time use. The company also noted in the announcement that their system "only needs an intermittent power source to operate and minimal cellular service to the tablet and app."

You can learn more about Stasis Labs and read the full article here.

Previous
Previous

Can Venture Capital Help Unlock 'Underdeveloped' Caltech?

Next
Next

PatientPop Announces $50M in Series C Funding